| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Human IL-35 concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human IL-35. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human IL-35 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human IL-35, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human IL-35. You can calculate the concentration of Human IL-35 in the samples by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 9.38 pg/mL |
|---|---|
| Detection Range | 15.63-1000 pg/mL |
| Total Assay Time | 3 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Human |
| Detection Method | Sandwich |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Human IL-35 in samples. No significant cross-reactivity or interference between Human IL-35 and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 9.38 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 3 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Sandwich ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant IL-35 standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis (2022) GUT. 10.1136/gutjnl-2021-324071
Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity (2022) Nature Communications. 10.1038/s41467-022-28338-0
Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunity (2025) Nature Communications. 10.1038/s41467-025-56002-w
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor (2023) OncoImmunology. 10.1080/2162402X.2023.2246322
Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function (2024) NEOPLASIA. 10.1016/j.neo.2024.101117
Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved (2019) Journal of Neuroinflammation. 10.1186/s12974-019-1606-1
Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response (2023) Biomolecules. 10.3390/biom14010001
Glutathione Redox Activity—An Adaptative Mechanism in Clear Cell Renal Cell Carcinoma (2026) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms27083509
Relation of T Cell Profile with Vitamin D Receptor and Vitamin D-Binding Protein Gene Polymorphisms in Atopy (2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms25169021
Evaluation of Salivary Cytokines and Vitamin D Levels in Periodontopathic Patients (2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms21082669
Cytokine Expression and Cytolytic Effect of Natural Killer Cells are Suppressed in Septic Shock (2025) SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 10.1111/sji.70023
Therapeutic potential of peptides from Ole e 1 in olive-pollen allergy (2019) Scientific Reports. 10.1038/s41598-019-52286-3
Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis (2022) CLINICAL RHEUMATOLOGY. 10.1007/s10067-022-06137-8
Overexpression of the transcription factor FOXP3 in lung adenocarcinoma sustains malignant character by promoting G1/S transition gene CCND1 (2015) TUMOR BIOLOGY. 10.1007/s13277-015-4616-3
Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson’s Disease (2023) Genes. 10.3390/genes14101913
Changes and significance of Th1/Th2 and Treg/Th17 cells and their cytokines in patients with alopecia areata (2024) EXPERIMENTAL CELL RESEARCH. 10.1016/j.yexcr.2024.114259
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy (2024) JOURNAL OF NEURO-ONCOLOGY. 10.1007/s11060-024-04689-0
Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson’s disease: a 1-year observational study (2024) JOURNAL OF NEURAL TRANSMISSION. 10.1007/s00702-024-02790-2
The correlation between Th17/Treg immune dysregulation and the disease severity in chronic spontaneous urticaria patients (2023) Immunity Inflammation and Disease. 10.1002/iid3.920
Cellular mediators in human leishmaniasis: Critical determinants in parasite killing or disease progression (2023) ACTA TROPICA. 10.1016/j.actatropica.2023.107037
Abnormalities of IL-12 Family Cytokine Pathways in Autosomal Dominant Polycystic Kidney Disease Progression (2024) Medicina-Lithuania. 10.3390/medicina60121971
Estimating the salivary levels of IL-35 in smokers with periodontitis: A cross sectional study (2023) Saudi Dental Journal. 10.1016/j.sdentj.2023.09.006
Cytokine, Genotype, and Viral Load Profile in the Acute and Chronic Hepatitis B (2020) VIRAL IMMUNOLOGY. 10.1089/vim.2020.0176
KDM3A promotes inhibitory cytokines secretion by participating in TLR4 regulation of Foxp3 transcription in lung adenocarcinoma cells (2017) Oncology Letters. 10.3892/ol.2017.5949
Interleukin-27 and interleukin-35 in de novo acute myeloid leukemia: expression and significance as biological markers (2019) Journal of Blood Medicine. 10.2147/JBM.S221301
